S29, T102 |
CK2 |
Degradation, interaction with α-catenin. |
(176, 178) |
Y30 |
JAK3 |
Interaction with α-catenin. |
(148) |
S33, S37, T41 |
GSK3β, NEK2 |
Degradation, contributes to mitosis. |
(24, 36, 38, 81) |
S45 |
CK1α, PKA, PKCζ |
Degradation, regulation of phosphorylation. |
(36, 115, 122, 123) |
Y64 |
JAK3, PTK6 |
Inhibits function in the nucleus, interaction with α-catenin. |
(148, 167) |
Y86 |
BCR-ABL, JAK3, SRC |
Increases the cytosolic and nuclear accumulation, interaction with α-catenin. |
(148, 165, 168, 169) |
T112 |
CK2, PKD1 |
Degradation, interaction with α-catenin, inhibits the nuclear localization. |
(178, 182) |
T120 |
PKD1 |
Interaction with α-catenin, inhibits the nuclear localization |
(182, 183) |
Y142 |
PTK6, FYN, FER, FGFR2, FGFR3, EGFR, TRKA |
Inhibits function in the nucleus, dissociation from adherence junctions, cytoplasmic accumulation. |
(25, 35, 37, 132, 167) |
S191 |
JNK2 |
Nuclear translocation. |
(151, 152) |
Y331, Y333 |
PTK6 |
Inhibits function in nucleus. |
(167) |
T393 |
CK2 |
Stabilization, enhances contributions in transcriptional regulations |
(176) |
S552 |
PKA, AKT |
Inhibits ubiquitination, stabilization, transcriptional regulation, and promoting tumor cell invasion. |
(124, 126, 127) |
S605 |
JNK2, p38γ |
Nuclear translocation. |
(131, 151, 152) |
Y654 |
MET, EGFR, SRC, BCR-ABL |
Dissociation from the E-cadherin/β-catenin/α-catenin complex, nuclear translocation. |
(128, 135, 164, 168, 169) |
Y670 |
MET |
Nuclear translocation. |
(135) |
S675 |
PAK1, PAK4, MEKK2, PKA |
Stabilization, inhibits ubiquitination, contributes to TCF/LEF transactivation. |
(123, 124, 129, 159, 160) |
S715 |
PKCδ |
Facilitate interaction with TRIM33 and degradation. |
(101) |
S718 |
PLK1 |
Regulation of centrosomes in M phase |
(86) |